Death reported in Brazil study of AstraZeneca COVID-19 vaccine

• Brazilian health regulator Anvisa reports that a volunteer has died in the Phase 3 clinical trial evaluating AstraZeneca (AZN -0.5%) and Oxford University's COVID-19 vaccine candidate, dubbed AZD1222 by the company.
• No details are available about the event other than that the person was Brazilian.
• The only other publicized adverse event was a participant in the U.K. who developed a rare spinal inflammatory disorder after inoculation, later deemed unlikely related to the vaccine.
• https://seekingalpha.com/news/3624404-death-reported-in-brazil-study-of-astrazeneca-covidminus-19-vaccine